We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLI:NYSEHoulihan Lokey, Inc. Analysis

Data as of 2026-04-08 - not real-time

$142.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Houlihan Lokey is trading around $142.9, well below its 20‑day ($141.0), 50‑day ($156.5) and 200‑day ($180.8) moving averages, indicating a bearish price environment. The stock sits just above the technical support at $134.4 and faces resistance near $149.6. Momentum is mixed – the RSI at 42 suggests neutral pressure while the MACD has turned bullish, offering a modest upside catalyst. Volatility is elevated at over 27% for the past 30 days, and volume trends are decreasing, flagging liquidity concerns. Fundamentally, the firm posts a 13% revenue growth, exceptional gross margins (~95%), and a solid ROE of ~20%, with a dividend yield of 1.71% backed by a 36% payout ratio. A DCF model values the shares at roughly $187, implying ~32% upside from current levels, though the PE multiple (21.9x) exceeds the industry average (16.8x). Recent material news notes a slowdown in restructuring activity—a key revenue segment—while the firm is bolstering its Capital Solutions group with senior hires and has filed a prospectus supplement for a potential secondary offering.
Overall, the stock appears undervalued relative to its intrinsic estimate, supported by strong profitability and sustainable dividends, but short‑term price pressure and sector‑specific headwinds suggest a cautious approach until technical signs of a reversal solidify.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price remains below key moving averages, indicating bearish momentum
  • MACD bullish crossover provides limited upside potential
  • Decreasing volume and high 30‑day volatility raise liquidity concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~30% upside
  • Sustainable dividend yield of 1.71% enhances total return
  • Strategic hires in Capital Solutions may revive restructuring revenue

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistently high gross margins and strong ROE indicate durable profitability
  • Low leverage (debt‑to‑equity ~22) and solid cash position support financial stability
  • Dividend sustainability and attractive payout ratio provide steady income

Key Metrics & Analysis

Financial Health

Revenue Growth13.00%
Profit Margin16.91%
P/E Ratio21.9
ROE20.47%
ROA12.08%
Debt/Equity21.67
P/B Ratio4.3
Op. Cash Flow$769.5M
Industry P/E16.8

Technical Analysis

TrendBearish
RSI41.9
Support$134.41
Resistance$149.59
MA 20$141.03
MA 50$156.50
MA 200$180.76
MACDBullish
VolumeDecreasing
Fear & Greed Index85.05

Valuation

Fair Value$187.02
Target Price$189.50
Upside/Downside32.64%
GradeUndervalued
TypeBlend
Dividend Yield1.71%

Risk Assessment

Beta0.93
Volatility27.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.